Healthcare Holding Schweiz AG Expands Its Reach
Healthcare Holding Schweiz AG, a prominent player in the medical device services sector, is thrilled to announce its acquisition of Effectum CH-Rep AG. This strategic move marks a significant step forward as the company broadens its portfolio in the medical technology landscape.
Acquisition Details
The integration of Effectum CH-Rep AG into Healthcare Holding Schweiz AG is a landmark decision, creating new avenues for growth and collaboration. The acquisition serves as a carve-out of services designated for Swiss Authorized Representative (CH-REP) from Effectum Medical AG. This strategic maneuver is particularly timely, considering the regulatory framework established by the Medical Devices Ordinance (MedDO SR 812.213). This ordinance necessitates that non-Swiss manufacturers appoint a CH-REP to market their products effectively in Switzerland.
Enhanced Service Offerings
By taking this significant step, Healthcare Holding Schweiz strengthens its position as a trusted partner for medical device manufacturers globally. Not only does this acquisition enable the company to provide a more comprehensive suite of services, but it also allows them to uphold and ensure compliance with evolving regulatory standards and practices.
“With Effectum CH-Rep, we are expanding our service portfolio to include the role of Swiss Authorized Representative,” stated Fabio Fagagnini, CEO of Healthcare Holding Schweiz AG. This addition empowers the team to focus on delivering innovative products and premium customer service, while ensuring that all necessary regulatory requirements are met professionally and efficiently.
Commitment to Quality Assurance
Emphasizing their dedication to regulatory adherence and excellence, Kim Züger, Head of Quality Management and the newly appointed Director of Effectum CH-Rep, conveyed, "Regulatory compliance is our top priority. By leveraging Effectum CH-Rep's expertise, we offer robust solutions not just to our suppliers but also extending our high standards to numerous other manufacturers.” This affirmation of commitment demonstrates the thoroughness with which Healthcare Holding Schweiz approaches its partnerships and services.
Future Directions
Michael Eggimann, a notable figure in the boardroom of Effectum Medical AG, highlighted the fruitful history of collaboration between their organizations and expressed confidence in the transition, “We have valued working with Healthcare Holding for many years, and this transition allows us to focus on enhancing our Legal Manufacturing offerings.” This shared sentiment showcases a unique partnership that prioritizes growth and customer satisfaction.
About Effectum CH-Rep AG and Healthcare Holding Schweiz AG
Effectum CH-Rep AG, located in Olten, provides valuable services to foreign manufacturers by acting as a Swiss Authorized Representative. They play a crucial role in supporting compliance with local registration requirements, working in conjunction with Swissmedic on several initiatives, and actively guiding manufacturers through the intricacies of the Swiss market.
Healthcare Holding Schweiz AG defines itself as an innovative platform committed to growth through acquisitions and strategic partnerships. Dedication to cutting-edge technology and customer fulfillment positions it as a leading provider in the Swiss medical technology arena. The drive for excellence is evident in their ongoing mission to elevate industry standards and provide outstanding opportunities for their employees.
About Winterberg Advisory GmbH
Winterberg Advisory GmbH operates as an independent family office that principally invests in small and medium enterprises. Their investment strategy focuses on the German-speaking region, effectively committing to healthcare and technology innovations through possibilities in private equity.
Frequently Asked Questions
What was the recent acquisition announced by Healthcare Holding Schweiz AG?
Healthcare Holding Schweiz AG recently acquired Effectum CH-Rep AG to enhance their service offerings in the medical device sector.
What is the role of Effectum CH-Rep AG?
Effectum CH-Rep AG acts as the Swiss Authorized Representative for foreign manufacturers, ensuring regulatory compliance for medical devices in Switzerland.
Why is this acquisition significant?
This acquisition strengthens Healthcare Holding Schweiz AG’s position as a comprehensive partner for medical technology manufacturers and enhances their service portfolio.
What does Healthcare Holding Schweiz AG focus on?
The company focuses on providing medical technology products and services and pursuing growth through strategic acquisitions and partnerships.
How does this acquisition impact regulatory compliance?
The acquisition allows Healthcare Holding Schweiz AG to ensure that all regulatory requirements are professionally met, reinforcing their commitment to quality in the medical field.
